MONTREAL, May 19 /CNW Telbec/ - As a proud sponsor for 16 years now of
the Bourse Fernand-Seguin, one of Canada's most prestigious fellowships
for scientific journalism, Merck would like to offer heartfelt
congratulations to this year's recipients. The 2011 edition marked the
30th anniversary of the competition.
"The Bourse Fernand-Seguin is a major stepping stone for young science
communicators in Québec, having helped launch several journalists'
promising careers. Merck is proud to be associated with this fellowship
and to encourage young communicators to continue to popularize
scientific knowledge, so that more people have access to the
information," says Christine Homsy, Director of Public Affairs at Merck
"The Association des communicateurs scientifiques du Québec would like
to acknowledge Merck Canada's contribution to the Bourse
Fernand-Seguin. Merck has been a key figure in the growth of this
competition for more than 16 years," adds Mathieu-Robert Sauvé,
President of the Association des communicateurs scientifiques du
Merck Canada is committed to supporting young people who share its
enthusiasm for research and scientific progress through various
projects, such as the Science Fairs, which it has been supporting for
the last 20 years, and the Bourse Fernand-Seguin. The company firmly
believes in its commitment to the community. Merck's contribution to
the Bourse Fernand-Seguin is a natural extension of its efforts to
raise public awareness about science.
Today's Merck is working to help the world be well. Merck is a global
health care leader with a diversified portfolio of prescription
medicines, vaccines, consumer and animal health products. In Canada,
Merck markets over 530 pharmaceutical, consumer and animal health
products and is a leader in a broad range of areas such as cardiology,
immunology, infectious diseases, respiratory, vaccines, women's health
and sun care, and is focused on expanding offerings in other areas,
including virology, oncology and diabetes.
Merck is one of the top 25 R&D investors in Canada, with an investment
of $95.4 million in 2009. Merck also has a large manufacturing facility
in Québec dedicated to the annual production of some 35 million units
including the Claritin® and Aerius® brands. Based in Montréal, Québec,
Merck employs over 1,600 people across Canada. For more information
about our operations in Canada, visit www.merck.ca.
SOURCE MERCK CANADA INC.
For further information: